ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 168 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,100,101 | -27.1% | 278,528 | -2.0% | 0.01% | -37.5% |
| Q4 2022 | $2,879,584 | +5.7% | 284,263 | +3.2% | 0.01% | 0.0% |
| Q3 2022 | $2,724,000 | -30.5% | 275,432 | -26.6% | 0.01% | -33.3% |
| Q2 2022 | $3,918,000 | -2.0% | 375,062 | -8.6% | 0.01% | +20.0% |
| Q1 2022 | $3,998,000 | -40.6% | 410,452 | -12.7% | 0.01% | -33.3% |
| Q4 2021 | $6,725,000 | -20.4% | 470,278 | +10.4% | 0.02% | -21.1% |
| Q3 2021 | $8,447,000 | +27.7% | 425,878 | +41.8% | 0.02% | +35.7% |
| Q2 2021 | $6,614,000 | +6.9% | 300,428 | +66.8% | 0.01% | 0.0% |
| Q1 2021 | $6,185,000 | – | 180,128 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |